Condition

Smith-Lemli-Opitz syndrome

Endocrine, Nutritional and Metabolic Diseases

Smith-Lemli-Opitz syndrome is an inborn error of cholesterol synthesis. It is inherited in an autosomal recessive pattern and is classed as a multiple malformation syndrome, meaning that a single underlying defect produces several physical differences at once. The cause is a mutation in the gene DHCR7, which encodes the enzyme 7-dehydrocholesterol reductase, a step in the body's manufacture of cholesterol. The effects vary widely between individuals, from mild intellectual disability and behavioural problems at the gentler end to malformations that are lethal at the severe end. The condition is recorded here as a description of what the medical literature holds, not as medical advice.

Facts
Classification
ICD-10 Chapter
IV: Endocrine, Nutritional and Metabolic Diseases 1
Communicable or Non-communicable
Non-Communicable 2
Causative Agent
Causative Agent (category)
Genetic / Hereditary 2
Prevalence Band
Rare (Under 1 in 2000) 3
Sources
1. Monarch Initiative: Smith-Lemli-Opitz syndrome - Monarch Initiative MONDO:0010035
Monarch InitiativeCross reference: ICD10CM
Quote, Cross reference: ICD10CM
ICD10CM:E78.72
View the Source
2. Smith-Lemli-Opitz syndrome (Wikipedia)
  • Lead section
    caused by a mutation in the enzyme 7-Dehydrocholesterol reductase encoded by the DHCR7 gene
  • Lead section [disease-category]
    It is an autosomal recessive, multiple malformation syndrome
View the Source
3. Orphadata (Orphanet): Orphadata: Epidemiology of rare diseases (en_product9_prev)
Orphadata (Orphanet)ORPHA:818
Quote, ORPHA:818
Prevalence at birth Value and class 1-9 / 100 000
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.

Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme